ABL1 and Parkinson disease: Studies in PD animal models and brain specimens from PD patients have revealed increased levels and activity of c-Abl in dopaminergic neurons with phosphorylation of protein substrates, such as α-synuclein and the E3 ubiquitin ligase [61].